Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease 2023-07-03
  2. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? 2013-04-18
  3. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity 2006-05-01

Studies

3 studies carry this tag.

Date range

2006 to 2023

Top journals

  • CNS neuroscience & therapeutics 1
  • Molecular neurodegeneration 1
  • The European journal of neuroscience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecular neurodegeneration 2023-07-03 Treatments

    Stroke and late-onset Alzheimer's disease (AD) are risk factors for each other; the comorbidity of these brain disorders in aging individuals represents a significant challenge in basic research and clinical practice.

  2. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. CNS neuroscience & therapeutics 2013-04-18 Treatments

    Alzheimer's disease (AD) has a devastating impact on aged people worldwide.

  3. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The European journal of neuroscience 2006-05-01 Treatments

    The pathogenesis of stroke, trauma and chronic degenerative diseases, such as Alzheimer's disease (AD), has been linked to excitotoxic processes due to inappropriate stimulation of the N-methyl-D-aspartate receptor (NMDA-R).

All topic tags with their study counts